Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Absentmindedness points to earlier symptoms of cerebral small vessel disease

Absentmindedness points to earlier symptoms of cerebral small vessel disease

Understanding ‘prodromal’ phase in Parkinson’s may prevent disease from developing

Understanding ‘prodromal’ phase in Parkinson’s may prevent disease from developing

Fibrinogen results in cognitive decline in Alzheimer’s disease, finds study

Fibrinogen results in cognitive decline in Alzheimer’s disease, finds study

Study explains why women are more prone to Alzheimer’s disease

Study explains why women are more prone to Alzheimer’s disease

Women's brains age slower than men's

Women's brains age slower than men's

AGS offers ringing endorsement of bipartisan Geriatrics Workforce Improvement Act

AGS offers ringing endorsement of bipartisan Geriatrics Workforce Improvement Act

Insilico to present its latest results in AI for Drug Discovery on CXOTalk Show

Insilico to present its latest results in AI for Drug Discovery on CXOTalk Show

Exercise may decrease cerebral blood flow and improve brain function in older adults

Exercise may decrease cerebral blood flow and improve brain function in older adults

New guidelines developed for effective management of neuropsychiatric symptoms of Huntington’s disease

New guidelines developed for effective management of neuropsychiatric symptoms of Huntington’s disease

New insight into anti-malaria drug

New insight into anti-malaria drug

USC researchers use AI to identify blood-based markers of Alzheimer's disease

USC researchers use AI to identify blood-based markers of Alzheimer's disease

Satiety hormone could decrease a person's risk of developing Alzheimer's disease

Satiety hormone could decrease a person's risk of developing Alzheimer's disease

Alzheimer's Association grants more than $800,000 to support the SPRINT MIND Study

Alzheimer's Association grants more than $800,000 to support the SPRINT MIND Study

Mechanism of inflammation initiation through NLRP3 inflammasome activation revealed

Mechanism of inflammation initiation through NLRP3 inflammasome activation revealed

Low doses of anti-HIV drug appear to reduce tau protein in neurons of Alzheimer’s patients

Low doses of anti-HIV drug appear to reduce tau protein in neurons of Alzheimer’s patients

Insilico Medicine to present latest advances in aging biomarker development at Longevity Leaders Conference

Insilico Medicine to present latest advances in aging biomarker development at Longevity Leaders Conference

Detecting Alzheimer’s in Hispanic patients may be more difficult than non-Hispanics

Detecting Alzheimer’s in Hispanic patients may be more difficult than non-Hispanics

PET imaging post-HBOT shows improvement in brain metabolism in Alzheimer’s disease

PET imaging post-HBOT shows improvement in brain metabolism in Alzheimer’s disease

Researchers unlock key process in human cells that contributes to cancer, neurodegenerative diseases, and aging

Researchers unlock key process in human cells that contributes to cancer, neurodegenerative diseases, and aging

Researchers demonstrate strong evidence connecting bacterial pathogen and Alzheimer's pathogenesisis

Researchers demonstrate strong evidence connecting bacterial pathogen and Alzheimer's pathogenesisis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.